Drug Type Induced pluripotent stem cells (iPSC) |
Synonyms SA-ROR2-NK 203 |
Target |
Mechanism ROR2 inhibitors(Tyrosine-protein kinase transmembrane receptor ROR2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Kidney Neoplasms | Preclinical | US | 13 Feb 2023 | |
Sarcoma | Preclinical | US | 13 Feb 2023 |